Guardant Health
GH
#2672
Rank
C$7.25 B
Marketcap
$58.80
Share price
-4.25%
Change (1 day)
128.84%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of December 2024 : -C$0.21 Billion

According to Guardant Health 's latest financial reports the company has -C$0.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$0.21 B157.74%
2022-12-31$C$81.66 M-90.07%
2021-12-31$C$0.82 B-52.44%
2020-12-31$C$1.72 B56.07%
2019-12-31$C$1.10 B54.88%
2018-12-31$C$0.71 B84.3%
2017-12-31$C$0.38 B262.28%
2016-12-31$C$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$1.26 B-729.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.85 B-2,011.30%๐Ÿ‡บ๐Ÿ‡ธ USA